AU3751689A - Vector for secretion of proteins directly into periplasm or culture medium - Google Patents
Vector for secretion of proteins directly into periplasm or culture mediumInfo
- Publication number
- AU3751689A AU3751689A AU37516/89A AU3751689A AU3751689A AU 3751689 A AU3751689 A AU 3751689A AU 37516/89 A AU37516/89 A AU 37516/89A AU 3751689 A AU3751689 A AU 3751689A AU 3751689 A AU3751689 A AU 3751689A
- Authority
- AU
- Australia
- Prior art keywords
- periplasm
- secretion
- vector
- culture medium
- proteins directly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19201388A | 1988-05-09 | 1988-05-09 | |
US192013 | 1988-05-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3751689A true AU3751689A (en) | 1989-11-29 |
Family
ID=22707875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU37516/89A Abandoned AU3751689A (en) | 1988-05-09 | 1989-05-04 | Vector for secretion of proteins directly into periplasm or culture medium |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0422049A4 (en) |
AU (1) | AU3751689A (en) |
IL (1) | IL90190A0 (en) |
WO (1) | WO1989010971A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2084992A1 (en) * | 1990-06-25 | 1991-12-26 | Osi Pharmaceuticals, Inc. | Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
US5571894A (en) * | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
US5939531A (en) * | 1991-07-15 | 1999-08-17 | Novartis Corp. | Recombinant antibodies specific for a growth factor receptor |
CA2077277A1 (en) * | 1991-09-09 | 1993-03-10 | John J. Donnelly | Cellular immunity vaccines from bacterial toxin-antigen conjugates |
US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
EP2327718B1 (en) | 2003-11-21 | 2016-03-23 | Pfenex, Inc. | Improved expression systems with SEC-system secretion |
JP2008507294A (en) | 2004-07-26 | 2008-03-13 | ダウ グローバル テクノロジーズ インコーポレイティド | Method for improved protein expression by strain genetic manipulation |
US7579005B2 (en) | 2005-11-28 | 2009-08-25 | E. I. Du Pont De Nemours And Company | Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags |
KR101491867B1 (en) | 2007-01-31 | 2015-02-10 | 피페넥스 인크. | Bacterial leader sequences for increased expression |
US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
JP5444553B2 (en) | 2007-04-27 | 2014-03-19 | フェネックス インコーポレイテッド | Methods for rapidly screening microbial hosts to identify specific strains with improved yield and / or quality of heterologous protein expression |
US8932586B2 (en) | 2011-09-06 | 2015-01-13 | Intrexon Corporation | Modified forms of Pseudomonas exotoxin A |
AU2014248768A1 (en) | 2013-03-12 | 2015-09-24 | Massachusetts Eye And Ear Infirmary | Modified mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseases |
CA3151082A1 (en) | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4892827A (en) * | 1986-09-24 | 1990-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
-
1989
- 1989-05-04 IL IL90190A patent/IL90190A0/en unknown
- 1989-05-04 WO PCT/US1989/001837 patent/WO1989010971A1/en not_active Application Discontinuation
- 1989-05-04 AU AU37516/89A patent/AU3751689A/en not_active Abandoned
- 1989-05-04 EP EP19890906964 patent/EP0422049A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0422049A4 (en) | 1991-11-13 |
EP0422049A1 (en) | 1991-04-17 |
WO1989010971A1 (en) | 1989-11-16 |
IL90190A0 (en) | 1989-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1482488A (en) | Leader sequences for the production of recombinant proteins | |
AU7865591A (en) | Method and means for extending the host range of insecticidal proteins | |
AU7400391A (en) | Method of using bar1 for secreting foreign proteins | |
AU2650988A (en) | Vectors and compounds for direct expression of activated human protein c | |
AU7869891A (en) | Novel enzyme preparations and methods for their production | |
AU4257389A (en) | Method for cultivation of bacteria | |
AU7873187A (en) | Method of culturing leukocytes | |
AU3533689A (en) | Tight binding of proteins to surfaces | |
AU3751689A (en) | Vector for secretion of proteins directly into periplasm or culture medium | |
AU2885489A (en) | Enzymatic hydrolysis of proteins | |
AU7130891A (en) | Vectors and compounds for expression of zymogen forms of human protein c | |
AU3460289A (en) | Novel protein, sequences containing the gene therefore, vectors, methods of preparation and use | |
AU7474787A (en) | Secretion of heterologous proteins from yeast | |
AU1652888A (en) | Fibrinolytic proteins | |
FI921059A0 (en) | Procedure for secretion of yeast beneficial proteins | |
AU3718484A (en) | Novel human interferon-`` polypeptide derivative | |
AU5602394A (en) | Chimeric blood coagulation proteins | |
AU4584193A (en) | Method of stabilizing hygral expansion of protein fiber product | |
AU8059391A (en) | Method of making peptides | |
AU4927390A (en) | Fusion proteins | |
AU2732988A (en) | Vectors and compounds for expression of zymogen forms of human protein c | |
AU3159784A (en) | Insuliin-Potentiating peptides from human growth hormome | |
AU3608589A (en) | Expression vectors for the preparation of infused proteins in microorganisms | |
AU4805093A (en) | Methods for treatment of enzyme preparations | |
AU7175591A (en) | Novel and improved technology for preservation of organs for transplantation |